Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma. [electronic resource]
Producer: 20160308Description: 42-6 p. digitalISSN:- 1423-0232
- Adult
- Aged
- Aged, 80 and over
- Antiviral Agents -- therapeutic use
- Carbamates
- Carcinoma, Hepatocellular -- epidemiology
- Drug Therapy, Combination
- Female
- Follow-Up Studies
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C, Chronic -- blood
- Humans
- Imidazoles -- therapeutic use
- Interferon alpha-2
- Interferon-alpha -- therapeutic use
- Isoquinolines -- therapeutic use
- Japan -- epidemiology
- Liver Neoplasms -- epidemiology
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- epidemiology
- Neoplasm Staging
- Oligopeptides -- therapeutic use
- Polyethylene Glycols -- therapeutic use
- Polymerase Chain Reaction
- Prognosis
- Pyrrolidines
- RNA, Viral -- genetics
- Recombinant Proteins -- therapeutic use
- Ribavirin -- therapeutic use
- Simeprevir -- therapeutic use
- Sulfonamides -- therapeutic use
- Valine -- analogs & derivatives
- Viral Load
- alpha-Fetoproteins -- analysis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.